Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127164811 | 12716481 | 1 | I | 20160812 | 20160823 | 20160906 | 20160906 | EXP | GB-MHRA-TPP10369071C3944619YC1470995455541 | GB-TEVA-687783ACC | TEVA | 51.00 | YR | F | Y | 105.00000 | KG | 20160906 | OT | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127164811 | 12716481 | 1 | PS | NAPROXEN. | NAPROXEN | 1 | 1000 MILLIGRAM DAILY; | 1000 | MG | U | U | 74129 | 500 | MG | BID | ||||
127164811 | 12716481 | 2 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 1 DOSAGE FORMS DAILY; EACH MORNING | 716 | DF | 0 | 1 | DF | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127164811 | 12716481 | 1 | Back pain |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127164811 | 12716481 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127164811 | 12716481 | Abdominal distension | |
127164811 | 12716481 | Joint swelling | |
127164811 | 12716481 | Lethargy | |
127164811 | 12716481 | Pain | |
127164811 | 12716481 | Pollakiuria |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127164811 | 12716481 | 1 | 20160812 | 0 | ||
127164811 | 12716481 | 2 | 20140827 | 0 |